XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2023
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

10. Stock-Based Compensation

Restricted Stock Units

During the three months ended March 31, 2023, the Company granted 126,931 restricted stock units to certain executives that vest over three years. During the three months ended March 31, 2022, the Company granted 1,057 and 132,730 restricted stock units to certain executives and employees that vest over one and three years, respectively.

Nonvested restricted stock units as of March 31, 2023, and changes during the three months ended March 31, 2023 (unaudited) were as follows:

 

 

Shares

 

 

Weighted Average Grant-Date Fair Value

 

Nonvested as of December 31, 2022

 

 

338,448

 

 

$

33.28

 

Granted

 

 

126,931

 

 

 

34.57

 

Vested

 

 

(8,426

)

 

 

35.95

 

Nonvested as of March 31, 2023

 

 

456,953

 

 

$

33.62

 

 

The Company's stock-based compensation expense related to the restricted stock units during the three months ended March 31, 2023 and 2022 (unaudited), which was included in General and administrative expenses within the Condensed Consolidated Statements of Income, was as follows:

 

 

Three Months Ended

 

(millions)

 

March 31, 2023

 

 

March 31, 2022

 

Stock-based compensation expense

 

$

1.1

 

 

$

1.3

 

 

As of March 31, 2023, there was $9.6 million of unrecognized stock-based compensation expense related to restricted stock units that are expected to be recognized over a weighted average remaining period of approximately 2.2 years.

Performance Share Units (“PSUs”)

During the three months ended March 31, 2023 and 2022, the Company granted 126,921 and 132,710 PSUs, respectively, to certain executives. The performance target is based on the achievement of a certain level of operating income, excluding depreciation and amortization, as well as certain other discretionary adjustments by the Board, over three-year performance periods. The ultimate number of shares issued could change depending on the Company’s results over the performance period. The maximum amount of shares that could be issued for the PSU's granted in 2023 ("2023 PSUs"), the PSU's granted in 2022 ("2022 PSUs") and the PSU's granted in 2021 ("2021 PSUs") are 253,842, 258,114 and 97,096, respectively. The Company is currently recognizing expense for the 2023 PSUs based on a payout of 130,729 shares, the 2022 PSUs based on a payout of 197,457 shares, and the maximum payout of 97,096 shares for the 2021 PSUs.

Nonvested PSUs as of March 31, 2023, and changes during the three months ended March 31, 2023 (unaudited), were as follows:

 

 

Shares

 

 

Weighted Average Grant-Date Fair Value

 

Nonvested as of December 31, 2022

 

 

177,605

 

 

$

31.94

 

Granted

 

 

126,921

 

 

 

34.57

 

Nonvested as of March 31, 2023

 

 

304,526

 

 

$

33.04

 

 

The Company's stock-based compensation expense related to PSUs during the three months ended March 31, 2023 and 2022 (unaudited), which was included in General and administrative expenses within the Condensed Consolidated Statements of Income, was as follows:

 

 

Three Months Ended

 

(millions)

 

March 31, 2023

 

 

March 31, 2022

 

Stock-based compensation expense

 

$

1.1

 

 

$

0.5

 

 

As of March 31, 2023, there was $9.0 million of unrecognized stock-based compensation expenses related to PSUs that are expected to be recognized over a weighted average remaining period of approximately 2.1 years. In addition, the Company could recognize additional future stock-based compensation expense of $4.3 million and $1.9 million for the 2023 PSUs and the 2022 PSUs, respectively, if the maximum performance target is achieved for each award.